EUR 32.66
(2.7%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -13.4 Million SEK | 18.3% |
2022 | -16.4 Million SEK | 8.48% |
2021 | -17.92 Million SEK | 47.53% |
2020 | -34.16 Million SEK | -339.46% |
2019 | -7.77 Million SEK | 69.87% |
2018 | -25.79 Million EUR | 41.66% |
2017 | -44.21 Million EUR | -1232.47% |
2016 | -3.31 Million EUR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q3 | -153.15 Million SEK | -39.31% |
2024 Q1 | -14.76 Million SEK | -13.81% |
2024 Q2 | -99.18 Million EUR | 41.85% |
2023 Q3 | -13.02 Million SEK | -14.43% |
2023 Q4 | -13.4 Million SEK | -2.85% |
2023 FY | -13.4 Million SEK | 18.3% |
2023 Q2 | -11.38 Million SEK | 26.05% |
2023 Q1 | -15.39 Million SEK | 6.13% |
2022 Q4 | -16.4 Million SEK | 7.69% |
2022 Q1 | -16.67 Million EUR | 6.96% |
2022 Q2 | -14.12 Million EUR | 15.3% |
2022 Q3 | -17.76 Million EUR | -25.8% |
2021 Q4 | -17.92 Million EUR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
SCHOTT Pharma AG & Co. KGaA | 47.97 Million EUR | 127.935% |
Carl Zeiss Meditec AG | 145.09 Million EUR | 109.236% |
Fielmann Aktiengesellschaft | 593.44 Million EUR | 102.258% |
Gerresheimer AG | 918.96 Million EUR | 101.458% |
Sartorius Aktiengesellschaft | 4.93 Billion EUR | 100.272% |
Sartorius Aktiengesellschaft | 4.93 Billion EUR | 100.272% |